The Hemophilia Federation of America (HFA) joins the National Organization for Rare Disorders (NORD) on February 29, and others around the world in observing Rare Disease Day. The purpose of this day is to focus attention on the needs of patients and families affected by rare diseases.
In the U.S., any disease affecting fewer than 200,000 Americans is considered rare. According to the National Institutes of Health (NIH), there are nearly 7,000 such diseases affecting nearly 30 million Americans — hemophilia is one of them.
Hemophilia is a rare genetic bleeding disorder, which affects only 20,000 people in the United States and results in excessive bleeding. Bleeding episodes may be external or internal into joints, muscles, the abdominal cavity, the brain, and other organs. Untreated bleeds can lead to crippling deformities of the joints or life threatening bleeds within the body. Currently, there is no cure, and medication needed to treat the disorder typically costs around $250,000 annually per person.
“I am proud that HFA is participating in this important day to help spread recognition of rare diseases as a global health challenge,” said Kimberly Haugstad, HFA Executive Director. “The celebration of Rare Disease Day has created a public awareness campaign and international advocacy movement for the millions of people living with a rare disorder.”
In 2008, Rare Disease Day began in Europe and was launched by EURORDIS (Rare Diseases Europe). Last year, it was observed in more than 60 countries, with a national sponsor in each country—NORD is the sponsor in the U.S.
HFA is proud to be one of 500 patient organizations, government entities, research institutions, and companies developing treatments to participate and observe “Patient Voice”—the theme for Rare Disease Day 2016.
Help spread awareness about Rare Disease Day by watching a video and sharing it with your family and friends.